NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN
Oslo University Hospital

 
 

 

  Nyheter på norsk  

Den Store Kule Dagen.

Informasjonsmøter om sarkom for pasienter og helsepersonell

NB Norsk forening for sarkompasienter stiftet!

 

 
 

The biology of mesenchymal tumours (sarcomas)

 

Our group is using functional genomics to characterise mesenchymal oncogenesis, that is the processes leading to formation of malignant connective tissue tumours, or sarcomas. The Norwegian Radium Hospital is a national centre of competence on this kind of tumours, and our research is done in close collaboration with our clinical colleagues, both locally and within the Scandinavian Sarcoma Group.

Main projects

Click on picture to enlarge
Click on picture to enlarge

  • Genomic profiling (Aberrations in copy number along the chromosomes, deletions and amplifications)
  • Expression profiling (genome-wide mRNA and microRNA levels)
  • Epigenomic profiling (DNA methylation, chromatin modification, transcription factor binding patterns)
  • Nuclear programming (FUGE project)
  • Chemotherapy studies (Partner in the EURAMOS clinical trial)
  • Experimental and clinical studies
  • Model system development (adipocyte and osteocyte differentiation, immortalised mesenchymal cell systems)

Click on left menu item "Research interests" to see more

Find out more about cancer from the Inside Cancer web site of Cold Spring Harbor Laboratories and about Sarcomas from the educational pages of the Shriver Foundation. For norske sider om sarkom, se sarkom.no.

 
 

The Liddy Shriver Sarcoma Initiative Funds A Global Collaborative Research Study on Liposarcoma

Myklebost part of international consortium

 

Paris, France – November 12, 2010 – The Liddy Shriver Sarcoma Initiative announced today that it is awarding a $250,000 grant to fund a global collaborative research study on liposarcoma. The unique project will be undertaken by a consortium of four investigators in three countries over the next two years. The announcement was made by Bruce Shriver, PhD, Co-Founder of the Liddy Shriver Sarcoma Initiative and Dr. David Thomas, one of the study’s principal investigators, at the annual meeting of the Connective Tissue Oncology Society in Paris.

Read the full press release

More  
 
 

Consortium on Cancer Stem Cells receives Grant for Centre for Research-based Innovation

Stem cell based targeted tumor therapy

 
A consortium of groups from Rikshospitalet-Radiumhospitalet HealthCentre and the University of Oslo, together with industry partners, were selectedof one of 14 grants alloted for Norwegian centres for research-based innovation, of which only two were within medicine.

The consortium will focus on the concept of a small population of stem-like cells being critical in tumour developement, and being able to regenerate the whole full-blown tumours on therapy faailure or metastasis. Isolation of such cells, and identification of their unique properties, may pawe the way for new diagnostics and therapies.

More  
 
 

Myklebost group becomes part of European Network of Excellence

EU FP6 grant awarded to Bone Tumour Network

 
Twenty-five European groups have joined forces to make a Network of Excellence that has been funded by the EU FP6 program. The Norwegian Radium Hospital will be responsible for a work package on Biology and Genetics of Osteosarcoma. Our participation is based on, and will strengthen, the National Sarcoma Competence Center at Dnr

More  
 
 

Putting the Norwegian Radium Hospital on the gene-therapy map

Correspondence in Nature

 


In a Commentary on "The future of gene therapy" in Nature (Cavazzana-Calvo et al. Nature 427, 779-781; 2004), a large map illustrated the number of gene therapy trials in different countries, indicating that no trials have been performed in Norway. Because Norway has the reputation of a prohibitive country when it comes to biotechnology, this incorrect impression can have serious consequences for the interest of pharmaceuticaal companies. Myklebost tries to set the record straight. Seven gene therapy trials have been performed in Norway, of which six at the Norwegian Radium Hospital.

Nature May 13th 2004

Read the letter   Apr 13, 2004 
 
>> Print this page  [6200 visits]